Medications for Wilms Tumor
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Wilms Tumor.
Found 2 Approved Drugs for Wilms Tumor
DOXOrubicin
Brand Names
Doxil, Adriamycin
DOXOrubicin
Brand Names
Doxil, Adriamycin
Form: Injection, Injectable
Method of administration: Intravenous, Intravitreal
FDA approval date: December 23, 1987
Classification: Anthracycline Topoisomerase Inhibitor
Doxorubicin is an anthracycline topoisomerase II inhibitor indicated: as a component of multiagent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer.
Dactinomycin
Generic Name
Dactinomycin
Dactinomycin
Generic Name
Dactinomycin
Form: Injection
Method of administration: Intravenous
FDA approval date: July 31, 2019
Classification: Actinomycin
Dactinomycin for injection is an actinomycin indicated for the treatment of: adult and pediatric patients with Wilms tumor, as part of a multi-phase, combination chemotherapy regimen.
Showing 1-2 of 2
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances